PKF275-055, an analog of vildagliptin, is a novel, selective, orally bioavailable, and long-acting DPP-4 inhibitor that has shown promising benefits in the prevention, protection, and treatment of diabetic neuropathy
Obesity and asthma have been linked through chronic systemic inflammation driven by adipokines such as leptin, adiponectin, TNF-, monocyte chemotactic protein-1 (MCP-1), and IL-6
This unexpected discovery has made scientists realize that Melanotan 2 may have a wider range of pharmacological effects, especially in the field of sexual health
The preclinical evidence for BPC-157s healing effects across multiple tissue types is robust and consistent across over 130 publications spanning three decades